瘢痕治療の世界市場 - 瘢痕の種類別 (拘縮／萎縮性／ケロイド瘢痕、妊娠線)・製品種類別 (レーザー製品、外用剤、注射剤)・エンドユース別・地域別：市場分析・シェア・動向・規模・予測
Scar Treatment Market, By Scar Type (Contracture, Atrophic, Keloid and Stretch Marks), By Product Type (Laser, Topical, and Injectables), By End-Use and by region - Analysis, Share, Trends, Size, & Forecast From 2014 - 2025
|発行||AnalystView Market Insights||商品コード||796166|
|出版日||ページ情報||英文 190 Pages
|瘢痕治療の世界市場 - 瘢痕の種類別 (拘縮／萎縮性／ケロイド瘢痕、妊娠線)・製品種類別 (レーザー製品、外用剤、注射剤)・エンドユース別・地域別：市場分析・シェア・動向・規模・予測 Scar Treatment Market, By Scar Type (Contracture, Atrophic, Keloid and Stretch Marks), By Product Type (Laser, Topical, and Injectables), By End-Use and by region - Analysis, Share, Trends, Size, & Forecast From 2014 - 2025|
|出版日: 2019年02月14日||ページ情報: 英文 190 Pages||
The scar treatment market is estimated to represent a global market of USD 15.06 billion by 2017 with growth rate of 9.4%.
Scars are usually observed when there has been significant damage to the skin layer, thus resulting in permanent damage in a particular area. Scar treatment is a way of using scientific methods to either topically or surgically gets rid of or reduces the impact of the scar. Based on NCBI research, over 100 million people are affected by scars every year, of which approximately 55 million elective operations and 50 million operations after trauma are common. Globally the market is witnessing an upward growth trend. It is estimated that the scar treatment market will reach a whopping 34.23 billion net worth by the year 2025.
Exposure to technological advances had radically improved the demand for this procedure. A few of fundamental drivers of this industry are the prevalence of skin diseases, the rampant rise of the beauty industry, increased number of accidents causing a scar. A larger disposable income is also among the primary reasons to opt for scar treatments. All thanks to the rise in the personal care industry, the market generated revenue of USD 15.06 billion in 2017. A growth rate of CAGR 9.4% has been forecasted up until 2025.
Increased demand for aesthetically enhancing procedures is ubiquitous. People have become extremely critical of they look and consequentially how that makes them feel. Scar treatment thus boosts their morale and hence the industry is observed to be emotionally driven.
Some of the most common scar types prevalent are keloid, contracture, stretch marks, and atropic. As aforementioned, people are becoming increasingly conscious about the way they look. It directly affects the perception of themselves and everyone around them. In order to feel good about themselves, and a growing number of individuals are willing to undergo skin corrective surgeries. People who have acne from an accident or reconstructive surgeries usually opt for skin corrective procedures.
Based on the data released by the American Burn Association approximately 44% of the hospital admissions are due to burning industries. Burn injuries result in something known as the hypertrophic burn scars, which are very visible and completely destroys self-confidence and self-worth. In these cases, it becomes necessary to take corrective scar treatment measures to improve the quality of life of such individuals. An increase in the number of skin conditions owing to lifestyle problems such as pollution, UV radiation exposure, sunburns is additionally responsible for the growth of this industry. An observed increase in the cases of psoriasis, eczema, and vitiligo is prevalent.
The major types of scar treatments can be broadly classified into the topical, surface, laser, injectable and surgical. While each of these categories is showing a growth pattern by their own merit, it has been noted that the topical application segment dominates the market. The topical procedure industry has contributed to about 60.1% in the year 2017. The major influencer for this is the low cost and high availability of topical applications.
From an end-user perspective, the industry can be categorized as domestic usage, hospital or derma clinics. Forecasted growth of approximately 11.3% is expected in the hospital use category. The technological advancements in laser treatment have resulted in enhanced and effective ablative and non-ablative treatments. They are further categorized as CO2 lasers, pulse dye lasers, and others. Topical treatment methods include gels, sprays, oils, creams; these are easily availed in an OTC format, usually very inexpensive in correlation with other procedures. Laser and injectable are among the growing trends in the overall industry.
North America holds a big chunk of the revenue share, as much as 40%. Growth of the market in this region is majorly attributed to the technology advancements, increasing demand for aesthetic procedures coupled with aging population. Besides this, Asia Pacific is growing with a CAGR of approximately 13% owing to the rising awareness among patient population regarding new scar treatment technologies.
Some of the other key players operating in the scar treatment market are: Sonoma Pharmaceuticals, Lumenis, Avita Medical, Cynosure, Inc., Molnlycke Health Care, Enaltus LLC, CCA Industries, Scarheal Inc., and NewMedical Technology, Inc. With respect to some merger and acquisitions, in 2017, Hologic Inc., broadcasted the acquisition of Cynosure Inc., in order to expand into the medical aesthetics business. Earlier on, Merz North America, a U.S. subsidiary of the global Merz Pharma GmbH, declared the acquisition of ON Light Sciences in August 2016.
The market size and forecast for each segment and sub-segments has been considered as below:
The scope of this report covers the market by its major segments, which include as follows:
Client can request additional company profiling as per specific requirements